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Background: Small subsets of studies have shown difference in mortality, length of
stay (LOS), number of percutaneous coronary intervention (PCI) and coronary artery
bypass surgery (CABG), in octogenarians presenting with acute myocardial infarction
(AMI).The aim of our study was to compare outcomes of AMI in octogenarians with
non octogenarians in a nationwide representative cohort
Methods: Using the Nationwide Inpatient Sample 2007, patients age ≥ 80 years
discharged with the primary diagnosis of AMI were identified through appropriate
ICD-9 clinical modification codes. Outcome variables included in-hospital mortality,
LOS, coronary revascularization procedures performed and discharge disposition.
Multivariate regression analysis was performed using appropriate survey commands
in STATA.
Results: Of the 135,634 discharges with primary diagnosis of AMI, 32,876 patients
(24.24%) were aged ≥80. The adjusted mortality was significantly higher (OR 1.2;
95% CI 1.1-1.4; p<0.001) and the number of coronary revascularization procedures
performed were significantly lower in octogenarians (OR 0.25; 95% CI 0.23-0.27; p<
0.001) as compared with patients <80 years of age. However, the mortality was
significantly lower in octogenarians undergoing coronary revascularization procedure
(OR 0.49; 95%CI 0.44-0.54; p< 0.001) compared with patients who did not get any
coronary revascularization procedure in the same age group. Octogenarians had
significantly longer LOS (5.5 days vs. 4.6 days; p<0.001) and were discharged to a
nursing home more often than those <80 years of age (OR 3.5; 95% CI 3.3-3.6,
p<0.001). Further, octogenarians undergoing cardiac procedures were less likely to be
discharged to nursing home (OR 0.51; 95%CI 0.48-0.53; p<0.001).
Conclusion: The in-hospital mortality is significantly lower in octogenarians
undergoing coronary revascularization procedure. Octogenarians undergoing coronary
revascularization procedure are often discharged to home.
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Background: Coronary endothelial dysfunction (CED) and subsequent clinical spasm
at the myocardial bridge (MB) segment has been proposed as a risk factor for adverse
cardiac events. There is limited data regarding age impact on CED severity in patients
(pts) with MB.
Methods: A total 622 consecutive patients (pts, Men; 371, 59.6%, mean age 52.9±
12.0 years) who underwent coronary angiography with acetylcholine (Ach)
provocation test were enrolled for this study. Study population was divided according
to age limit of fifty years.
Results: Regarding baseline characteristics, age group more than 50 years had more
hypertension (55.9% vs. 35.0%, p<0.001), diabetes (13.2% vs. 2.7%, p<0.001), and
dyslipidemia(26.3% vs. 14.4 %, P<0.001). Ach test clinical endpoints were similar
between the two groups. However, in age group more than 50 years; the frequency of
significant Ach-induced spasm, response to A2 dose, mulitvessels spasm and >70%
narrowing on QCA were significant higher on multivariate analysis (Table).
Conclusion: In pts with MB, older age (more than 50 years) was associated with more
frequent significant spasm and multivessel spasm as assessed with Ach provocation
test. Special care should be emphasized in these patients.
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Background: Drug-eluting stents are standard of care for the treatment of obstructive
coronary artery disease and are increasingly being used to treat patients with complex
clinical and lesion characteristics. In addition, with over 350 million people in the
world over the age of 70, evaluating clinical outcomes following percutaneous coronary
intervention (PCI) in the elderly becomes important. The Global RESOLUTE Clinical
Trial Program is evaluating the Resolute zotarolimus-eluting stent (R-ZES) in a set of
trials specifically designed with consistent endpoint definitions; We pooled patient-
level data from 5 trials that have completed their primary endpoint to evaluate the
safety and efficacy of the R-ZES in the elderly population.
Methods: A total of 5130 patients received the R-ZES in the following trials; Resolute
First-In-Man (139), Resolute All Comers (1140), Resolute International (2349),
Resolute United States (1402), and Resolute Japan (100). We compared baseline and
1-year clinical outcomes for patients < 70 years of age, vs. ≥ 70 years of age.
Results: Compared with patients < 70 (N = 3455) at the index procedure, more patients
≥ 70 were female (33.1% vs. 21.2%, p < 0.001); had diabetes (34.3% vs. 27.8%, p =
< 0.001); and less presented with ACS (39.5% vs. 42.5%, p = 0.04). At 1 year, higher
rates of death (3.9% vs. 0.9%, p < 0.001), and cardiac death (2.3% vs. 0.6%, P < 0.001)
in the older patients drove higher rates of the composites of MACE (9.2% vs. 6.7%, p
= 0.001) and TVF (8.7% vs. 6.9%, p = 0.02); yet age did not affect the rates of target-
vessel myocardial infarction (2.7% vs 3.1%, p = 0.536), clinically-driven TLR (3.3%
vs. 3.2%, p = 0.93) or TVR (4.6% vs 4.2%, p = 0.55).
Conclusion: These data support the use of the R-ZES for PCI in patients over 70.
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Background: Elderly constitute an increasing proportion of all patients, who are
admitted for acute coronary syndromes (ACS) to the hospital. Since increased age is
a risk factor itself for death and recurrent MI, physicians are faced with immediate
decisions about the different management strategies in this patient group, which will
affect short- and long term outcome. The purpose of this study was to identify
predictors of inhospital mortality in either interventionally or conservatively treated
patients in a large consecutive series of elderly (> 75 years), presenting to our hospital
with ACS.
Methods: Between 01/05 and 11/07 1001 patients > 75 ys. were treated for ACS in
our hospital. Records were evaluated and patients were identified on the basis of their
discharge diagnosis. Adverse outcome, defined as the appearance of death, myocardial
infarction, complicated hospital stay, pneumonia and interventional complications like
bleeding, stroke and reinfarction etc. was evaluated. Using a multivariate regression
analysis, we identified factors which predicted inhospital mortaliy.
Results: Out of 1001 patients (mean age 81±5 Jahre, 512 (51.1% female), Killip-class
1,4±0,75, EF 47±15%) 776 [77.5 %] were treated invasively; wherease 247 [22.5%]
were teated conservatively. A total of 62 deaths (6.2%) occurred in hospital, mortality
was significantly higher in conservatively treated patients (p<0.001). Mortality rates
were 15.6% in conservatively and 3.5% in interventionally treated patients. Early risks
were highest for patients with a high GRACE-score (p=0.002), eligibility for a
conservative treatment (p=0.012), Killip-class ≥ 2 (p=0.031) and prior stroke
(p=0.031). In this model age had had no predictive value for inhospital mortality
(p=0.354).
Conclusion: In our large data base of 1001 patients age was not a predictor of
inhospital mortality. Therefore advanced age should not be the main factor in decision
making for conservative or invasive treatment in elderly patients with ACS and an
invasive strategy should be offered also to elderly patients.
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